Company registration number 07132283 (England and Wales)
SUNNYHURST NURSERIES (HOLDINGS) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
SUNNYHURST NURSERIES (HOLDINGS) LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
SUNNYHURST NURSERIES (HOLDINGS) LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
286,977
297,850
Investments
5
2,377,110
2,377,110
2,664,087
2,674,960
Current assets
Debtors
6
635
20,590
Cash at bank and in hand
812,822
850,552
813,457
871,142
Creditors: amounts falling due within one year
7
(55,868)
(54,366)
Net current assets
757,589
816,776
Total assets less current liabilities
3,421,676
3,491,736
Creditors: amounts falling due after more than one year
8
(1,173,000)
(1,173,000)
Net assets
2,248,676
2,318,736
Capital and reserves
Called up share capital
9
100
100
Share premium account
26,900
26,900
Profit and loss reserves
2,221,676
2,291,736
Total equity
2,248,676
2,318,736

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

SUNNYHURST NURSERIES (HOLDINGS) LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 11 May 2026
B J Marshall
Director
Company Registration No. 07132283
SUNNYHURST NURSERIES (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Sunnyhurst Nurseries (Holdings) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 94 Blackgate Lane, Tarleton, Nr Preston, Lancashire, PR4 6UT.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Turnover

Turnover represents amounts receivable for hire charge income on assets provided prior to the balance sheet date net of VAT.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Freehold land and buildings
2% per annum, straight line basis
Plant and machinery
25% per annum, reducing balance basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

SUNNYHURST NURSERIES (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

1.6
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

SUNNYHURST NURSERIES (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

SUNNYHURST NURSERIES (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
-
-
3
Dividends
2025
2024
£
£
Interim paid
446,000
272,208
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2025 and 31 December 2025
452,000
189,239
641,239
Depreciation and impairment
At 1 January 2025
161,482
181,907
343,389
Depreciation charged in the year
9,040
1,833
10,873
At 31 December 2025
170,522
183,740
354,262
Carrying amount
At 31 December 2025
281,478
5,499
286,977
At 31 December 2024
290,518
7,332
297,850
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
2,377,110
2,377,110
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
635
20,590
SUNNYHURST NURSERIES (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
7
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
53,156
52,231
Other creditors
2,712
2,135
55,868
54,366
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
1,173,000
1,173,000

The company has issued and fully paid 623,000 5% non-redeemable preference shares of £1 each and 550,000 4% redeemable preference shares of £1 each.

 

9
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
A Ordinary shares of 1p each
3,486
3,486
35
35
B Ordinary shares of 1p each
3,414
3,414
34
34
C Ordinary shares of 1p each
500
500
5
5
D Ordinary shares of 1p each
2,600
2,600
26
26
10,000
10,000
100
100
SUNNYHURST NURSERIES (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
10
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Advances
Opening balance
Amounts repaid
Closing balance
£
£
£
Director's loan account
9,500
(9,500)
-
9,500
(9,500)
-

The advances were interest free, repayable upon demand and the company held no security in their respect.

2025-12-312025-01-01falsefalsefalse15 May 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityB J Marshall071322832025-01-012025-12-31071322832025-12-31071322832024-12-3107132283core:LandBuildings2025-12-3107132283core:OtherPropertyPlantEquipment2025-12-3107132283core:LandBuildings2024-12-3107132283core:OtherPropertyPlantEquipment2024-12-3107132283core:CurrentFinancialInstruments2025-12-3107132283core:CurrentFinancialInstruments2024-12-3107132283core:Non-currentFinancialInstruments2025-12-3107132283core:Non-currentFinancialInstruments2024-12-3107132283core:ShareCapital2025-12-3107132283core:ShareCapital2024-12-3107132283core:SharePremium2025-12-3107132283core:SharePremium2024-12-3107132283core:RetainedEarningsAccumulatedLosses2025-12-3107132283core:RetainedEarningsAccumulatedLosses2024-12-3107132283core:ShareCapitalOrdinaryShareClass22025-12-3107132283core:ShareCapitalOrdinaryShareClass22024-12-3107132283core:ShareCapitalOrdinaryShareClass32025-12-3107132283core:ShareCapitalOrdinaryShareClass32024-12-3107132283core:ShareCapitalOrdinaryShareClass42025-12-3107132283core:ShareCapitalOrdinaryShareClass42024-12-3107132283core:ShareCapitalOrdinaryShareClass52025-12-3107132283core:ShareCapitalOrdinaryShareClass52024-12-3107132283core:ShareCapitalOrdinaryShares2025-12-3107132283core:ShareCapitalOrdinaryShares2024-12-3107132283bus:Director12025-01-012025-12-3107132283core:LandBuildingscore:OwnedOrFreeholdAssets2025-01-012025-12-3107132283core:PlantMachinery2025-01-012025-12-31071322832024-01-012024-12-3107132283core:LandBuildings2024-12-3107132283core:OtherPropertyPlantEquipment2024-12-31071322832024-12-3107132283core:LandBuildings2025-01-012025-12-3107132283core:OtherPropertyPlantEquipment2025-01-012025-12-3107132283core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3107132283core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3107132283bus:OrdinaryShareClass22025-01-012025-12-3107132283bus:OrdinaryShareClass32025-01-012025-12-3107132283bus:OrdinaryShareClass42025-01-012025-12-3107132283bus:OrdinaryShareClass52025-01-012025-12-3107132283bus:OrdinaryShareClass22025-12-3107132283bus:OrdinaryShareClass22024-12-3107132283bus:OrdinaryShareClass32025-12-3107132283bus:OrdinaryShareClass32024-12-3107132283bus:OrdinaryShareClass42025-12-3107132283bus:OrdinaryShareClass42024-12-3107132283bus:OrdinaryShareClass52025-12-3107132283bus:OrdinaryShareClass52024-12-3107132283bus:AllOrdinaryShares2025-12-3107132283bus:AllOrdinaryShares2024-12-3107132283bus:PrivateLimitedCompanyLtd2025-01-012025-12-3107132283bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3107132283bus:FRS1022025-01-012025-12-3107132283bus:AuditExemptWithAccountantsReport2025-01-012025-12-3107132283bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP